Showing 1 – 20 of 58
Relevance | Newest | Oldest |
  • JAMA Oncology Brief Report
    April 25, 2024

    Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

    Giacomo听Montagna,听MD, MPH; Mary M.听Mrdutt,听MD, MS; Susie X.听Sun,听MD; Callie听Hlavin,听MD, MPH; Emilia J.听Diego,听MD; Stephanie M.听Wong,听MD, MPH; Andrea V.听Barrio,听MD; Astrid Botty听van den Bruele,听MD; Neslihan听Cabioglu,听MD, PhD; Varadan听Sevilimedu,听MBBS, DrPH; Laura H.听Rosenberger,听MD, MS; E. Shelley听Hwang,听MD, MPH; Abigail听Ingham,听MBchB; B盲rbel听Papassotiropoulos,听MD; Bich Doan听Nguyen-Str盲uli,听MD; Christian听Kurzeder,听MD; Danilo D铆az听Aybar,听MD; Denise听Vorburger,听MD; Dieter Michael听Matlac,听MD; Edvin听Ostapenko,听MD; Fabian听Riedel,听MD; Florian听Fitzal,听MD; Francesco听Meani,听MD; Franziska听Fick,听MD; Jacqueline听Sagasser,听MD; J枚rg听Heil,听MD, PhD; Hasan听Karanl谋k,听MD; Konstantin J.听Dedes,听MD; Laszlo听Romics,听MD, PhD; Maggie听Banys-Paluchowski,听MD, PhD; Mahmut听Muslumanoglu,听MD; Maria Del Rosario Cueva听Perez,听MD; Marcelo Ch谩vez听D铆az,听MD; Martin听Heidinger,听MD; Mathias K.听Fehr,听MD; Mattea听Reinisch,听MD; Mustafa听Tukenmez,听MD; Nadia听Maggi,听MD; Nicola听Rocco,听MD, PhD; Nina听Ditsch,听MD, PhD; Oreste Davide听Gentilini,听MD; Regis R.听Paulinelli,听MD, PhD; Sebasti谩n Sol茅听Zarhi,听MD; Sherko听Kuemmel,听MD, PhD; Simona听Bruzas,听MD; Simona听di Lascio,听MD; Tamara K.听Parissenti,听MD; Tanya L.听Hoskin,听MS; Uwe听G眉th,听MD; Valentina听Ovalle,听MD; Christoph听Tausch,听MD; Henry M.听Kuerer,听MD, PhD; Abigail S.听Caudle,听MD; Jean-Francois听Boileau,听MD, MSc; Judy C.听Boughey,听MD; Thorsten听K眉hn,听MD, PhD; Monica听Morrow,听MD; Walter P.听Weber,听MD
    Abstract Full Text
    online first
    JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578

    This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.

  • JAMA Surgery Original Investigation
    March 27, 2024

    Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women

    Danielle R.听Heller,听MD, MHS; Bayley听Axelrod,听BS, MHA; Varadan听Sevilimedu,听MBBS, PhD; Monica听Morrow,听MD; Babak J.听Mehrara,听MD; Andrea V.听Barrio,听MD
    Abstract Full Text
    online first
    JAMA Surg. 2024; 10.1001/jamasurg.2024.0118

    This cohort study examines the association between race and ethnicity and long-term quality of life after unilateral axillary lymph node dissection in women with breast cancer.

  • JAMA Surgery Invited Commentary
    January 17, 2024

    Robotic Nipple-Sparing Mastectomy鈥擱eady for Prime Time?

    Monica听Morrow,听MD
    Abstract Full Text
    JAMA Surg. 2024; 159(3):276-276. 10.1001/jamasurg.2023.7007
  • JAMA Oncology Brief Report
    June 9, 2022

    Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer鈥揜elated Lymphedema

    Giacomo听Montagna,听MD, MPH; Jennifer听Zhang,听MD; Varadan听Sevilimedu,听MBSS, DrPH; Jillian听Charyn,听BS; Kelly听Abbate,听BS; Ethan A.听Gomez,听BS; Babak听Mehrara,听MD; Monica听Morrow,听MD; Andrea V.听Barrio,听MD
    Abstract Full Text
    free access
    JAMA Oncol. 2022; 8(8):1195-1200. 10.1001/jamaoncol.2022.1628

    This cohort study evaluate rates and risk factors associated with breast cancer鈥搑elated lymphedema in patients treated with axillary lymph node dissection.

  • JAMA Surgery Original Investigation
    June 8, 2022

    Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets

    Jonas A.听Nelson,听MD, MPH; Robyn N.听Rubenstein,听MD; Kathryn听Haglich,听BS, MS; Jacqueline J.听Chu,听BA; Shen听Yin,听PhD; Carrie S.听Stern,听MD; Monica听Morrow,听MD; Babak J.听Mehrara,听MD; Mary L.听Gemignani,听MD, MPH; Evan听Matros,听MD, MMSc, MPH
    Abstract Full Text
    free access
    JAMA Surg. 2022; 157(8):702-711. 10.1001/jamasurg.2022.2065

    This case-control study examines data from NSQIP, the SEER program, and the National Cancer Database to evaluate trends in lumpectomy and mastectomy rates in the treatment of breast cancer.

  • JAMA Oncology Comment & Response
    May 12, 2022

    Is Regional Nodal Radiotherapy Necessary for Patients With cN1 and ypN0 Breast Cancer After Neoadjuvant Chemotherapy?鈥擱eply

    Andrea V.听Barrio,听MD; Giacomo听Montagna,听MD, MPH; Monica听Morrow,听MD
    Abstract Full Text
    JAMA Oncol. 2022; 8(6):942-943. 10.1001/jamaoncol.2022.0316
  • JAMA Oncology Brief Report
    October 7, 2021

    Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy鈥擜 Rare Event

    Andrea V.听Barrio,听MD; Giacomo听Montagna,听MD, MPH; Anita听Mamtani,听MD; Varadan听Sevilimedu,听MBBS, DrPH; Marcia听Edelweiss,听MD; Deborah听Capko,听MD; Hiram S.听Cody听III,听MD; Mahmoud听El-Tamer,听MD; Mary L.听Gemignani,听MPH, MD; Alexandra听Heerdt,听MD; Laurie听Kirstein,听MD; Tracy-Ann听Moo,听MD; Melissa听Pilewskie,听MD; George听Plitas,听MD; Virgilio听Sacchini,听MD; Lisa听Sclafani,听MD; Audree听Tadros,听MD; Kimberly J.听Van Zee,听MS, MD; Monica听Morrow,听MD
    Abstract Full Text
    free access
    JAMA Oncol. 2021; 7(12):1851-1855. 10.1001/jamaoncol.2021.4394

    This cohort study examines nodal recurrence rates in patients with clinically node-positive cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy.

  • JAMA Surgery Invited Commentary
    September 1, 2021

    Quality of Life and Breast Cancer Surgery

    Monica听Morrow,听MD
    Abstract Full Text
    online only
    JAMA Surg. 2021; 156(10):e213759. 10.1001/jamasurg.2021.3759
  • JAMA Oncology Special Communication
    January 28, 2021

    Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement

    Rachel A.听Freedman,听MD, MPH; Christina A.听Minami,听MD, MFA, MS; Eric P.听Winer,听MD; Monica听Morrow,听MD; Alexander K.听Smith,听MD, MS, MPH; Louise C.听Walter,听MD; Mina S.听Sedrak,听MD, MS; Haley听Gagnon,听BS; Adriana听Perilla-Glen,听MBA; Hans听Wildiers,听MD; Tanya M.听Wildes,听MD, MDSI; Stuart M.听Lichtman,听MD; Kah Poh听Loh,听MBBCh, BAO; Etienne G. C.听Brain,听MD, PhD; Pamela S.听Ganschow,听MD; Kelly K.听Hunt,听MD; Deborah K.听Mayer,听PhD, RN, AOCN; Kathryn J.听Ruddy,听MD, MPH; Reshma听Jagsi,听MD, DPhil; Nancy U.听Lin,听MD; Beverly听Canin; Barbara K.听LeStage,听MHP; Anna C.听Revette,听PhD; Mara A.听Schonberg,听MD, MPH; Nancy L.听Keating,听MD, MPH
    Abstract Full Text
    JAMA Oncol. 2021; 7(4):609-615. 10.1001/jamaoncol.2020.7582

    This special contribution reviews the literature on the risk of breast cancer events among breast cancer survivors and the harms and benefits of mammography to develop expert consensus guidelines that facilitate tailored decision-making for routine surveillance mammography in breast cancer survivors 75 years or older.

  • JAMA Surgery Original Investigation
    August 26, 2020

    Changes in Reoperation After Publication of Consensus Guidelines on Margins for Breast-Conserving Surgery: A Systematic Review and Meta-analysis

    M. Luke听Marinovich,听PhD; Naomi听Noguchi,听PhD; Monica听Morrow,听MD; Nehmat听Houssami,听PhD
    Abstract Full Text
    free access online only
    JAMA Surg. 2020; 155(10):e203025. 10.1001/jamasurg.2020.3025

    This systematic review and meta-analysis examines the reoperation rates reported in the literature before and after publication of the 2014 Society of Surgical Oncology鈥揂merican Society for Radiation Oncology guideline for surgical management of invasive cancer.

  • JAMA Oncology Comment & Response
    May 7, 2020

    De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ鈥擱eply

    Monica听Morrow,听MD; Eric听Winer,听MD
    Abstract Full Text
    JAMA Oncol. 2020; 6(7):1118-1118. 10.1001/jamaoncol.2020.0819
  • JAMA Oncology Original Investigation
    February 6, 2020

    Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer

    Allison W.听Kurian,听MD, MSc; Kevin C.听Ward,听PhD; Paul听Abrahamse,听MA; Ann S.听Hamilton,听PhD; Dennis听Deapen,听DrPH; Monica听Morrow,听MD; Reshma听Jagsi,听MD, DPhil; Steven J.听Katz,听MD, MPH
    Abstract Full Text
    free access online only
    JAMA Oncol. 2020; 6(4):e196400. 10.1001/jamaoncol.2019.6400

    This population-based cohort study examines the association of germline genetic testing results with locoregional and systemic therapy use in women aged 20 years or older diagnosed with breast cancer.

  • JAMA Oncology Viewpoint
    December 12, 2019

    De-escalating Breast Cancer Surgery鈥擶here Is the Tipping Point?

    Monica听Morrow,听MD; Eric P.听Winer,听MD
    Abstract Full Text
    JAMA Oncol. 2019; 6(2):183-184. 10.1001/jamaoncol.2019.4849

    This Viewpoint provides a perspective on recent trials focused on reducing the incidence of surgery in the treatment of breast cancer.

  • JAMA Oncology Editorial
    October 3, 2019

    Crafting a JAMA Oncology Clinical Challenge

    Monica听Morrow,听MD; Mary L.听Disis,听MD
    Abstract Full Text
    free access
    JAMA Oncol. 2019; 5(12):1695-1695. 10.1001/jamaoncol.2019.4001
  • JAMA Oncology Comment & Response
    March 14, 2019

    Undissected Axilla and Axillary Radiotherapy鈥擨n Reply

    Monica听Morrow,听MD; Reshma听Jagsi,听MD, DPhil; Steven J.听Katz,听MD, MPH
    Abstract Full Text
    JAMA Oncol. 2019; 5(5):742-743. 10.1001/jamaoncol.2019.0050
  • JAMA Surgery Comment & Response
    December 12, 2018

    Guidelines Do Not Proscribe Surgeons Performing Genetic Testing鈥擱eply

    Steven J.听Katz,听MD, MPH; Monica听Morrow,听MD; Allison W.听Kurian,听MD, MS
    Abstract Full Text
    JAMA Surg. 2018; 154(3):269-270. 10.1001/jamasurg.2018.4885
  • JAMA Surgery Original Investigation
    October 1, 2018

    Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer

    Steven J.听Katz,听MD, MPH; Irina听Bondarenko,听MS; Kevin C.听Ward,听PhD, MPH; Ann S.听Hamilton,听PhD; Monica听Morrow,听MD; Allison W.听Kurian,听MD, MSc; Timothy P.听Hofer,听MD, MSc
    Abstract Full Text
    free access
    JAMA Surg. 2018; 153(10):909-916. 10.1001/jamasurg.2018.2001

    This population-based study quantifies the association of attending surgeon attitudes with rates of genetic testing after diagnosis of breast cancer using information from patient and surgeon surveys merged to SEER and genetic testing data.

  • JAMA Oncology Original Investigation
    August 1, 2018

    Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer

    Allison W.听Kurian,听MD, MSc; Kevin C.听Ward,听PhD, MPH; Ann S.听Hamilton,听PhD; Dennis M.听Deapen,听DrPH; Paul听Abrahamse,听MS; Irina听Bondarenko,听MS; Yun听Li,听PhD; Sarah T.听Hawley,听PhD, MPH; Monica听Morrow,听MD; Reshma听Jagsi,听MD, DPhil; Steven J.听Katz,听MD, MPH
    Abstract Full Text
    free access has multimedia
    JAMA Oncol. 2018; 4(8):1066-1072. 10.1001/jamaoncol.2018.0644

    This population-based cohort study examines the effect of multiple-gene sequencing on the experiences and treatment outcomes of patients with breast cancer.

  • JAMA Oncology Original Investigation
    July 12, 2018

    Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer

    Monica听Morrow,听MD; Reshma听Jagsi,听MD, DPhil; M. Chandler听McLeod,听PhD; Dean听Shumway,听MD; Steven J.听Katz,听MD
    Abstract Full Text
    free access
    JAMA Oncol. 2018; 4(11):1511-1516. 10.1001/jamaoncol.2018.1908

    This survey study examines the propensity of surgeons to use axillary lymph node biopsy alone for axillary management in women with early-stage breast cancer undergoing breast-conserving surgery.

  • JAMA Oncology Comment & Response
    May 1, 2018

    Trend Analysis on Reoperation After Lumpectomy for Breast Cancer鈥擱eply

    Monica听Morrow,听MD; Paul听Abrahamse,听MA; Steven J.听Katz,听MD
    Abstract Full Text
    JAMA Oncol. 2018; 4(5):747-747. 10.1001/jamaoncol.2017.5261